He discusses his session titled “The Microbiome and Fatty Liver Disease,” which he presented at Harvard’s Nonalcoholic Fatty Liver Disease (NAFLD): Mechanisms and Novel Therapeutics symposium.
In this video, Steven Grinspoon, MD, speaks about effective treatments of steatosis in patients with HIV, including whether tesamorelin could decrease liver fat in men and women living with HIV and...
Donald E. Fetterolf, MD, discusses the major advantage of amniotic membrane therapy: the ability of the allografts to attract stem cells to the region of the wound in order to rebuild damaged tissues.
Faculty member Joel Heidelbaugh, MD, FAAFP, FACG, Clinical Professor, Departments of Family Medicine and Urology, University of Michigan Medical School; talks about testosterone replacement, when a...
